Lidocaine Hydrochloride

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

Supply fragility

Several kinds of pressure are visible at once — each line below is a condition that historically precedes supply trouble, and this market is stacking them.

• in shortage now+25
• Class I/II recall on same molecule/form in past 12 months+8
• price down 34% year over year+8
• sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

sterile injectable · 4 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

• Eugia Pharma Specialities LimitedOAIIndia
  analysis · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →